SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22% SLD 0.42 ▲0.00% MBG 0.21 ▲0.00% FDC 3.93 ▼-0.76% LF1 1.87 ▼-2.12% LGF 2.38 ▲0.86% DN1 98.00 ▼-0.17% WMX 1.58 ▼-2.46% RG8 2.52 ▲0.40% CTS 0.89 ▲2.89% TET 0.42 ▲1.20% MRE 1.68 ▲0.00% BST 0.27 ▲3.85% EFR 0.01 ▲0.00% RIV 1.20 ▼-0.42% KIT 1.80 ▲0.56% EMUCA 0.89 RF1 3.38 ▲0.00% AIX 9.00 ▲0.22%

AKA Aureka Limited

Basic Materials · Gold · website
$0.14
52wk 0.07 – 0.19
Overall
60.3
Value
63.6
Growth
50.0
Health
88.4
Quality
0.0
Momentum
92.2
Dividend
—
Price
About Aureka Limited

Aureka Limited engages in the mineral exploration business in Australia. It explores for gold and silver deposits. The company's flagship project is the 100% owned Stawell Corridor gold project which includes Irvine and Langi Logan gold projects located in North-West of Melbourne, Victoria. The company was formerly known as Navarre Minerals Limited and changed its name to Aureka Limited in December 2024. Aureka Limited was incorporated in 2007 and is based in Melbourne, Australia.

Commodity exposure

Primary exposure: Gold (detected from the company profile: gold)

Gold primary
4,213.80 USD/oz
1m: -3.5% · 1y: 9.7%
Silver
61.52 USD/oz
1m: -4.9% · 1y: 33.7%
Price analytics

Returns

1 day 7.4%
1 week 7.4%
1 month 16.0%
3 months 76.8%
6 months 38.1%
1 year 26.1%
3 years 663.2%

Risk

Volatility (1y ann.) 91.3%
Beta vs ASX 200 1.03
Sharpe (1y) 0.65
VaR 95% (1-day) -8.3%
Max drawdown (1y) -62.2%
Off 1-year high -21.6%

Technicals

RSI(14) 62
vs 50DMA 30.8%
vs 200DMA 31.1%
Trend Golden cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown (2 Oct 2026)
Value 63.6
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
66
Price / Sales
0
Growth 50.0
Revenue growth (1y)
100
Revenue CAGR (3y)
—
EPS growth (1y)
0
EPS CAGR (3y)
—
Financial Health 88.4
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
—
Current ratio
74
Debt / Equity
100
Quality (Profitability & Cash Flow) 0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income —
No meaningful dividend — pillar excluded from the overall score.
Momentum 92.2
6-month return vs ASX 200
100
Price vs 200-day average
100
Price vs 50-day average
100
Position in 52-week range
63

Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).

Score history
Key metrics
Market cap
$30.29M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
-0.02
Dividend yield
—
Payout ratio
0.0%
Beta
—
EV / EBITDA
-3.79
Price / Book
3.22
ROE
-121.7%
Operating margin
-170.6%
Net margin
0.0%
Total cash
$2.30M
Total debt
$537,305
Current ratio
2.06
Debt / Equity
0.13
Free cash flow
$-3.84M
Avg volume
233,473
Latest annual results (FY ending 30 Jun 2025)
  • Revenue—
  • Gross profit—
  • Operating income—
  • Net income—
  • Diluted EPS-0.07
  • Free cash flow—
  • Net debt—
Sector peers (Basic Materials)
TickerMkt cap P/EScore
BHP $311.13B 22.0 68.1
RIO $268.04B 15.5 58.1
NEM $174.41B 14.5 82.2
FMG $49.85B 12.1 60.7
NST $34.22B 20.7 76.0
EVN $26.76B 17.9 79.4
S32 $22.08B 14.5 67.1
JHX $20.94B 112.7 45.6